MYLAN 2264 MYLAN 2264 (Terazosin 2 mg)

Pill imprint MYLAN 2264 MYLAN 2264 has been identified as Terazosin hydrochloride 2 mg.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MYLAN 2264 MYLAN 2264

Terazosin hydrochloride 2 mg MYLAN 2264 MYLAN 2264 Front
Terazosin hydrochloride 2 mg MYLAN 2264 MYLAN 2264 Back
Terazosin hydrochloride 2 mg MYLAN 2264 MYLAN 2264
Terazosin hydrochloride
Imprint:
MYLAN 2264
MYLAN 2264
Strength:
2 mg
Color:
Black / Purple
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-2264
Inactive Ingredients:
lactose anhydrous
silicon dioxide
D&C Red No. 28
D&C Red No. 33
FD&C Blue No. 1
gelatin
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
titanium dioxide
ferrosoferric oxide
ammonia
propylene glycol
dimethicone
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0937 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)